REGENERON PHARMACEUTICALS (1REGN.MI) Forecast, Price Target & Analyst Ratings

BIT:1REGN • US75886F1075

Current stock price

667.6 EUR
+39.4 (+6.27%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REGENERON PHARMACEUTICALS (1REGN.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€726.78
+ 8.87% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$9.29
Revenue Estimate
3.524B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.11%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€726.78
Upside
+ 8.87%
From current price of €667.60 to mean target of €726.78, Based on 36 analyst forecasts
Low
€554.09
Median
€733.38
High
€922.52

Price Target Revisions

1 Month
9.16%
3 Months
9.16%

Price Target Summary

36 Wall Street analysts provided a forecast for the next 12 months for 1REGN.MI. The average price target is 726.78 EUR. This implies a price increase of 8.87% is expected in the next year compared to the current price of 667.6.
The average price target has been revised upward by 9.16% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1REGN Current Analyst Rating1REGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

1REGN Historical Analyst Ratings1REGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
81.11%
1REGN.MI was analyzed by 36 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about 1REGN.MI.
In the previous month the buy percentage consensus was at a similar level.
1REGN.MI was analyzed by 36 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
$9.29
Revenue Estimate
3.524B
Revenue Q2Q
16.34%
EPS Q2Q
13.04%
Number of Analysts
25

Next Earnings Revisions

Revenue (1 Month)
0.40%
Revenue (3 Months)
0.40%
EPS (1 Month)
-12.90%
EPS (3 Months)
-12.90%

Next Earnings Summary

1REGN.MI is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 9.29 EUR and the consensus revenue estimate is 3.52B EUR.
The next earnings revenue estimate has been revised upward by 0.4% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
1REGN.MI revenue by date.1REGN.MI revenue by date.
13.117B
7.76%		14.202B
8.27%		14.343B
0.99%		16.047B
11.88%		17.701B
10.31%		19.198B
8.46%		20.291B
5.69%		21.425B
5.59%		22.076B
3.04%		22.145B
0.31%		20.759B
-6.26%
EBITDA
YoY % growth
1REGN.MI ebitda by date.1REGN.MI ebitda by date.
4.757B
-14.97%		4.701B
-1.17%		4.419B
-6.01%		5.478B
23.98%		6.156B
12.38%		7.209B
17.11%		7.599B
5.41%		7.933B
4.40%		11.028B
39.01%		11.43B
3.65%		9.495B
-16.93%
EBIT
YoY % growth
1REGN.MI ebit by date.1REGN.MI ebit by date.
4.336B
-17.46%		4.218B
-2.71%		3.875B
-8.13%		5.181B
33.71%		6.204B
19.75%		7.189B
15.88%		8.115B
12.88%		9.178B
13.10%		9.484B
3.33%		9.708B
2.36%		8.848B
-8.86%
Operating Margin
1REGN.MI operating margin by date.1REGN.MI operating margin by date.
33.05%29.70%27.02%32.29%35.05%37.45%39.99%42.84%42.96%43.84%42.62%
EPS
YoY % growth
1REGN.MI eps by date.1REGN.MI eps by date.
43.78
3.25%		45.64
4.25%		44.38
-2.76%		46.75
5.35%		54.83
17.27%		62.02
13.13%		68.68
10.74%		74.65
8.69%		80.73
8.14%		82.95
2.75%		77.36
-6.73%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		9.29
13.04%		10.88
-15.59%		12.17
2.91%		12.29
7.46%		9.68
4.18%		14.80
36.02%		11.96
-1.72%		11.96
-2.68%
Revenue
Q2Q % growth		3.524B
16.34%		3.878B
5.51%		4.08B
8.68%		4.272B
9.98%		3.491B
-0.94%		4.021B
3.69%		3.944B
-3.33%		3.998B
-6.41%
EBITDA
Q2Q % growth		1.229B
68.15%		1.478B
9.36%		1.848B
22.50%		1.457B
-9.79%		1.144B
-6.92%		1.695B
14.68%		1.439B
-22.13%		1.433B
-1.65%
EBIT
Q2Q % growth		1.004B
66.23%		1.223B
12.25%		1.412B
27.22%		1.439B
34.30%		1.015B
1.10%		1.557B
27.31%		1.315B
-6.87%		1.304B
-9.38%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1REGN.MI Yearly Revenue VS Estimates1REGN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1REGN.MI Yearly EPS VS Estimates1REGN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60 80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
11.80%
EPS Next 5 Year
10.96%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.77%
Revenue Next 5 Year
8.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
14.31%
EBIT Next 5 Year
10.45%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REGENERON PHARMACEUTICALS / 1REGN.MI Forecast FAQ

What do analysts expect the price target to be for REGENERON PHARMACEUTICALS (1REGN.MI)?

36 analysts have analysed 1REGN.MI and the average price target is 726.78 EUR. This implies a price increase of 8.87% is expected in the next year compared to the current price of 667.6.

When does REGENERON PHARMACEUTICALS (1REGN.MI) report earnings?

REGENERON PHARMACEUTICALS (1REGN.MI) will report earnings on 2026-04-27.

What are the consensus estimates for 1REGN stock next earnings?

The consensus EPS estimate for the next earnings of REGENERON PHARMACEUTICALS (1REGN.MI) is 9.29 EUR and the consensus revenue estimate is 3.52B EUR.

What is the number of analysts for 1REGN stock?

The number of analysts covering REGENERON PHARMACEUTICALS (1REGN.MI) is 36.